Navigation Links
Raptor Pharmaceuticals Closes $10 Million Private Placement
Date:6/30/2008

ressing orphan indications."

Kim R. Tsuchimoto, Raptor's Chief Financial Officer, stated, "This funding is critical for the execution of our drug development programs. We are grateful to our existing and new investors who support our passionate efforts in bringing safer and more effective therapeutics to market."

About Raptor Pharmaceuticals Corp.

Raptor Pharmaceuticals Corp. ("Raptor") consists of a preclinical division and a clinical division, which together form a continuous set of specialized competencies to develop Raptor's pipeline of drug product candidates from early stage to clinical stage through to commercialization. Raptor's preclinical division bioengineers novel drug candidates and drug-targeting platforms derived from the human receptor-associated protein ("RAP") and related proteins, while Raptor's clinical division advances clinical-stage product candidates towards marketing approval and commercialization. Raptor's initial clinical programs include the treatment of aldehyde dehydrogenase ("ALDH2") deficiency, nephropathic cystinosis and non-alcoholic steatohepatitis ("NASH").

Raptor preclinical programs target cancer, neurodegenerative disorders and infectious diseases. HepTide(TM) is designed to utilize engineered RAP-based peptides conjugated to drugs to target delivery to the liver to potentially treat primary liver cancer and hepatitis. NeuroTrans(TM) represents engineered RAP peptides created to target receptors in the brain and are currently undergoing preclinical evaluation at Stanford University for their ability to enhance the transport of therapeutics across the blood-brain barrier.

Raptor's clinical division executes the clinical development of: 1) Raptor's internally developed product candidates; 2) new chemical entities in-licensed for mid-to-late stage clinical development; 3) currently approved drugs with potential in additional indications; and 4) treatments that may be repurposed or reformulated fo
'/>"/>

SOURCE Raptor Pharmaceuticals Corp.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Raptor Pharmaceuticals Acquires Orphan Clinical Program
2. Raptor Pharmaceuticals Corp. Enters Agreements to Advance Clinical Pipeline
3. Raptor Pharmaceuticals Corp. Receives FDA Orphan Drug Designation for Cysteamine in Huntingtons Disease
4. Raptor Pharmaceuticals Corp. To Present at BIO 2008 International Convention
5. Raptor Pharmaceuticals Corp. Announces Presentation at 5th International Cystinosis Conference 2008
6. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
7. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
8. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
9. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
10. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
11. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)...EW YORK, Nov. 30 The Mi...MJFF) today announced $1.5 million in total awards...lly disease-modifying therapies for Parkinson,s di...proaches to Drug Discovery for Parkinson,s Disease...oration, plc (NYSE: ELN ), a neuroscience-based ...
(Date:11/30/2009)... CHANGCHUN, China and LOS ANGELES, Nov. 30 /PR...uticals, Inc. (OTC Bulletin Board: CYXN; ,China Yo...g manufacturer, distributor and,retailer of pharma...t has,completed preparation for distribution of me... Chinese government recently formalized the nation...
(Date:11/30/2009)...BOSTON and COPENHAGEN, Nov. 30 Exi...oday that the Harvard Medical School ICCB-Longwood...s a MicroRNA Screening Center of Excellence. ICCB...l, and associated hospitals and institutions, for ...Ai libraries. ,, MicroRNAs are a novel class of...
(Date:11/28/2009)... The Vanuatu National Advisory Committe...ional Communication (SNC) Project in collaboration...systems Ltd. of New Zealand have generated prelimi...t will form the background for the country’s...vention on Climate Change (UNFCCC). , ...
Breaking Biology Technology:The Michael J. Fox Foundation Announces $1.5 Million in Funding to Advance Development of Drug Targets for Disease-Modifying Parkinson's Disease Treatments 2The Michael J. Fox Foundation Announces $1.5 Million in Funding to Advance Development of Drug Targets for Disease-Modifying Parkinson's Disease Treatments 3China Yongxin Pharmaceuticals Inc. to Distribute Medicines on the Essential Drug List 2China Yongxin Pharmaceuticals Inc. to Distribute Medicines on the Essential Drug List 3Exiqon Recognizes Harvard Medical School Core Facility as MicroRNA Screening Center of Excellence 2Exiqon Recognizes Harvard Medical School Core Facility as MicroRNA Screening Center of Excellence 3Preliminary Climate and Sea Level Changes for Vanuatu Through the Application of SimCLIM 2Preliminary Climate and Sea Level Changes for Vanuatu Through the Application of SimCLIM 3Preliminary Climate and Sea Level Changes for Vanuatu Through the Application of SimCLIM 4
...ship Completes CTI,s Transformation to Commercial ... SEATTLE, April 24 Cell Therapeutics, Inc.,(Nasd...ilips, most recently,Vice President and General Ma... President of CTI with direct responsibilities for...ive August 1, 2008. Philips, responsibilities,will...
... April 23 Anadys Pharmaceuticals,Inc. (Nasdaq: A...arter 2008,financial results on Wednesday, April 3... Anadys will hold a conference call and webcast to...and highlights and to provide an update on,its dev...5:00 p.m. Eastern,Daylight Time. A live webcast of...
...iz., April 23 ImaRx Therapeutics,Inc. (Nasdaq: I...agreement,with Abbott Laboratories pursuant to whi...million non-recourse promissory note with Abbott i...ase. As a result, full title to,the urokinase asse...product, all regulatory and clinical documentation...
Other Biology Technology:Veteran Drug Industry Executive to Become President of CTI 2Veteran Drug Industry Executive to Become President of CTI 3Veteran Drug Industry Executive to Become President of CTI 4Anadys Pharmaceuticals to Report First Quarter 2008 Financial Results 2ImaRx Therapeutics Satisfies Abbott Note Obligation Associated With the Acquisition of Urokinase 2ImaRx Therapeutics Satisfies Abbott Note Obligation Associated With the Acquisition of Urokinase 3
(Date:11/26/2009)... Whitehead researchers have developed a new type ...ific genes and proteins used by pathogens, accordi...cell cultures genes are present in two copies: one.... Gene inactivation by mutation is therefore ineff...econd copy usually remains active and takes over. ...
(Date:11/26/2009)...ococcus Aureus ) and other drug-resistant bacteria... prototype devices have been developed to offer sa...ls. , Two prototype devices have been developed:....g. hands and feet) in hospitals and public spaces...her to shoot bacteria-killing agents into infested...
(Date:11/25/2009)...tomach, may be used to boost resistance to, or slo...hool of Medicine researchers report in a study pub...cience . , Parkinson,s disease is caused by a de...idbrain known as the substantia nigra, which is re...tion of dopamine in late-stage Parkinson,s causes ...
Breaking Biology News(10 mins):Knockouts in human cells point to pathogenic targets 2Plasma produces KO cocktail for MRSA 2Plasma produces KO cocktail for MRSA 3Hormone ghrelin can boost resistance to Parkinson's disease 2As Greenland melts 10423 1As Greenland melts 10423 2MU research team establishes family tree for cattle other ruminants 10421 1MU research team establishes family tree for cattle other ruminants 10421 2EPA fellow studies effect of mercury in toads 10419 1EPA fellow studies effect of mercury in toads 10419 2
...hagic fever have been reported in Angola. Of these...irst 6 cases, bringing the number of affected prov...ern part of the country. , Mobile surveillance tea...rday when vehicles were attacked and damaged by lo...no surveillance teams were operational today in th...
...ns researchers report that two proteins best known...her to turn the liver into a sugar-producing facto...tion of sugar is a damaging problem in people with...rget for future drugs to fight the disease, the re...liver,s production of sugar is a back-up plan that...
...ns researchers report that two proteins best known...her to turn the liver into a sugar-producing facto...tion of sugar is a damaging problem in people with...rget for future drugs to fight the disease, the re...liver,s production of sugar is a back-up plan that...
Other Biology News:WHO suspends Marburg work, appeals for new funds 2Computational verification of protein-protein interactions by orthologous co-expression 2Computational verification of protein-protein interactions by orthologous co-expression 3Future diabetes drugs may target new protein interaction 2Future diabetes drugs may target new protein interaction 3
Custom Human Cytokine Antibody Array, Choose from hundreds of proteins. from Raybiotech, Inc.
Goat Anti-Mouse Ig + IgM Antibody, FITC Conjugated from Cayman Chemical
CopyControl Induction Solution from EPICENTRE Biotechnologies
RNase III from Ambion
Biology Products: